GRAL
GRAIL Inc.
$64.42
-2.35
(-3.52%)
Mkt Cap
2.76B
Volume
789,352
52W Range
29.95-118.84
Sector
Healthcare
Beta
3.22
EPS (TTM)
-10.37
P/E Ratio
-7.70
Revenue (TTM)
156.12M
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 147.17M | 125.59M | 93.11M | 55.55M | 14.61M | 0 | 0 | 0 |
| Net Income | (408.35M) | (2.03B) | (1.47B) | (5.40B) | (1.25B) | (312.16M) | (244.85M) | (275.72M) |
| EPS | -11.11 | -63.54 | -47.20 | -173.87 | -40.18 | -2.52 | -1.99 | -2.42 |
| Free Cash Flow | (299.01M) | (582.36M) | (608.69M) | (584.17M) | (758.06M) | (243.91M) | (249.13M) | (225.25M) |
| FCF / Share | -8.14 | -18.26 | -19.60 | -18.81 | -24.41 | -1.97 | -2.02 | -1.97 |
| Operating CF | (299.01M) | (577.16M) | (595.80M) | (561.31M) | (688.13M) | (232.00M) | (245.79M) | (209.26M) |
| Total Assets | 2.92B | 2.98B | 4.56B | 5.60B | 9.74B | 706.30M | 635.52M | 686.85M |
| Total Debt | 98.01M | 68.14M | 84.41M | 96.01M | 110.56M | 62.99M | 42.04M | 2.52M |
| Cash & Equiv | 249.73M | 214.23M | 97.29M | 241.60M | 221.16M | 170.19M | 143.19M | 95.09M |
| Book Value | 2.58B | 2.50B | 3.65B | 4.65B | 9.43B | 561.84M | 550.53M | 600.37M |
| Return on Equity | -0.16 | -0.81 | -0.40 | -1.16 | -0.13 | -0.56 | -0.44 | -0.46 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.78M | 43.60M | 36.19M | 35.54M | 31.84M | 38.25M | 28.65M | 31.97M | 26.72M | 30.33M | 20.72M | 22.41M |
| Net Income | (93.19M) | (99.18M) | (88.98M) | (113.98M) | (106.21M) | (97.07M) | (125.69M) | (1.59B) | (218.91M) | (5.49M) | (891.45M) | (193.04M) |
| EPS | -2.29 | -2.44 | -2.46 | -3.18 | -3.10 | -2.89 | -3.94 | -51.06 | -7.05 | -0.18 | -28.71 | -6.22 |
| Free Cash Flow | (87.49M) | (62.97M) | (63.63M) | (77.33M) | (95.07M) | (93.79M) | (105.55M) | (173.19M) | (209.83M) | (132.79M) | (160.58M) | (141.77M) |
| FCF / Share | -2.15 | -1.55 | -1.76 | -2.21 | -2.77 | -2.94 | -3.31 | -5.58 | -6.76 | -4.28 | -5.17 | -4.57 |
| Operating CF | (86.99M) | (63.78M) | (63.24M) | (76.97M) | (95.01M) | (93.49M) | (104.58M) | (171.80M) | (207.29M) | (128.90M) | (157.51M) | (138.91M) |
| Total Assets | 2.80B | 2.92B | 2.60B | 2.70B | 2.85B | 2.98B | 3.12B | 3.27B | 4.75B | 4.56B | N/A | N/A |
| Total Debt | 51.03M | 98.01M | 58.59M | 62.16M | 64.32M | 68.14M | 72.19M | 76.11M | 79.94M | 84.41M | N/A | N/A |
| Cash & Equiv | 69.34M | 249.73M | 126.89M | 127.43M | 133.90M | 214.23M | 853.55M | 958.85M | 974.10M | 97.29M | N/A | N/A |
| Book Value | 2.50B | 2.58B | 2.24B | 2.31B | 2.41B | 2.50B | 2.59B | 2.70B | 3.99B | 3.65B | N/A | N/A |
| Return on Equity | -0.04 | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 | -0.05 | -0.59 | -0.05 | -0.00 | N/A | N/A |
GRAL News
GRAL Deadline: GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL
GRAL 1-WEEK DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline
GRAIL, Inc. (NASDAQ: GRAL) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors
GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Grail, Inc. Securities Lawsuit - Contact SueWallSt
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline
Lost Money on GRAIL, Inc. (GRAL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
GRAL Class Reminder: GRAIL, Inc. Investors are Reminded of the Upcoming August 4 Deadline in the Filed Securities Fraud Class Action to Recover Losses